This report displays which states continue to allow tele-health prescriptions for medications for opioid use disorder (MOUD) through an interactive map. Each state is assigned a color based on whether or not the state explicitly allows tele-health prescriptions. It provides a snapshot of current tele-health MOUD state policy 18 months into the pandemic.
Treatment Resources
- COVID / Coronavirus related
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Advocates / Peers
- Medical
- Policymakers
This report recommends that states implement measures to track treatment of opioid use disorder (OUD) as a means to optimize utilization of resources. It identifies eight core measures including OUD diagnoses, provider availability, treatment initiation, use of medications for opioid use disorder, and post treatment outcomes.
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Health Insurers
This is a toolkit by the American Hospital Association (AHA) that provides resources to hospitals and health systems to share with clinicians and patients to enhance partnerships within their communities. It also highlights several innovative programs with links to them.
- Cautious Opioid Prescribing
- Educational
- Family Support
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Health Insurers
- Hospitals
- Medical
This is a report from the Mental Health Commission of Canada that summarizes an 18-month project on opioid use disorder (OUD) stigma and gives a scoping literature review as well as the results of key informant interviews and focus groups involving first responders, persons with lived experience of substance and/or opioid use, policymakers, and other service providers.
- Educational
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Employers
- First Responders
- Harm Reduction Specialists
- Health Insurers
- Hospitals
- Law Enforcement
- Medical
- Pharmacies
- Policymakers
This study develops a typology of the stigma related to opioid use, showing how multiple dimensions of stigma continue to fundamentally hinder the response to the crisis.
The paper explains how public stigma is driven by stereotypes about people with opioid use disorders, such as their perceived dangerousness or perceived moral failings, which translate into negative attitudes toward people with opioid use disorders. Additionally, it explains that enacted stigma describes the behavioral manifestations of public stigma, including discrimination and social distancing. Finally, the study emphasizes that public and enacted stigma, in turn, lead to the delivery of suboptimal care and undermine access to treatment and harm reduction services.
- Cautious Opioid Prescribing
- Educational
- Medications for Opioid Use Disorder
- Overdose prevention
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Criminal Justice
- First Responders
- Harm Reduction Specialists
- Law Enforcement
- Medical
- Pharmacies
- Policymakers
This in an annual summit sponsored by National Academy of Medicine and Shatterproof that brings together stakeholders to discuss the negative impact of stigma on people with substance use disorders and elevate action-oriented strategies to address and eliminate the harms caused by stigma. More information from the 2021 summit can be found here and the 2022 summit can be found here.
- Educational
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Harm Reduction Specialists
This is an academic paper that provides a commentary on the role that stigma plays in substance use disorder, how it manifests, and the evidence base for combating it.
- Educational
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Employers
- First Responders
- Harm Reduction Specialists
- Health Insurers
- Hospitals
- Law Enforcement
- Medical
- Pharmacies
- Policymakers
This is an academic paper that provides commentary on the impact of stigma on a person with substance use disorder (SUD), with a specific focus on how stigmatizing language sustains stigma. Stigma is associated with detrimental effects on treatment outcomes, health care providers, treatments, research, policies, and society as a whole.
- Educational
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Employers
- First Responders
- Harm Reduction Specialists
- Health Insurers
- Hospitals
- Law Enforcement
- Medical
- Pharmacies
- Policymakers
The Rockefeller Institute's Stories from Sullivan series combines aggregate data analysis with on-the-ground research in affected communities to provide insight into what the opioid problem looks like in this rural county, how the community has responded, and what kinds of policies have the best chances of making a difference.
- Educational
- Family Support
- Medications for Opioid Use Disorder
- Overdose prevention
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Law Enforcement
- Medical
- Policymakers
This is a toolkit from the Ohio Department of Job and Family Services that equips local workforce boards in the state to help solve the employment issues related to the opioid crisis, such as absenteeism, decreased productivity, and worker shortages. Recovery-friendly workplaces and working with those with opioid addiction and in recovery are discussed.
- Educational
- Housing, Education, and Employment
- Employers
This is a report from the Deloitte Center for Health Solutions on how data analytics can help health plans and pharmacy benefit managers (PBM) combat the opioid crisis by improving prevention and treatment strategies, informed by interviews with 35 clinical, pharmacy, data analytics, and policy leaders from health plans and PBMs across the country.
- Cautious Opioid Prescribing
- Medications for Opioid Use Disorder
- Community Health Officials
- Employers
- Health Insurers
- Hospitals
- Medical
- Pharmacies
- Policymakers
This is a report from the U.S. Interagency Council on Homelessness that identifies strategies communities, providers, and policymakers can use to address the intersection of homelessness and the opioid crisis and highlights several helpful resources developed by federal and national partners to support such efforts.
- Housing, Education, and Employment
- Medications for Opioid Use Disorder
- Overdose prevention
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Policymakers